GABY Inc.
GABY Inc. GABY.CN Peers
See (GABY.CN) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
Stock Comparison
GABY.CN vs NBLY.TO Comparison
GABY.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GABY.CN stands at 3.67M. In comparison, NBLY.TO has a market cap of 835.48M. Regarding current trading prices, GABY.CN is priced at $0.01, while NBLY.TO trades at $18.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GABY.CN currently has a P/E ratio of -0.08, whereas NBLY.TO's P/E ratio is -25.48. In terms of profitability, GABY.CN's ROE is +2.91%, compared to NBLY.TO's ROE of -0.05%. Regarding short-term risk, GABY.CN is less volatile compared to NBLY.TO. This indicates potentially lower risk in terms of short-term price fluctuations for GABY.CN.